Nucleic acid phosphate backbone

The nucleic acid phosphate backbone is the repeating structural framework of DNA and RNA, composed of alternating sugar (deoxyribose or ribose) and phosphate groups linked by phosphodiester bonds. This backbone provides the necessary stability and negative charge that allows for the formation of the double helix and facilitates interactions with positively charged proteins, such as histones and transcription factors (National Human Genome Research Institute, 2023). In a therapeutic context, the phosphate backbone is a primary target for antisense oligonucleotides (ASOs) and RNA interference (RNAi) therapies, where chemical modifications like phosphorothioate linkages are employed to enhance metabolic stability and cellular uptake (Nature Reviews Drug Discovery, 2017). Additionally, many traditional chemotherapeutic agents, such as alkylating agents and platinum-based drugs, interact with or cause damage to the backbone, leading to strand breaks and the inhibition of replication in cancer cells (PubMed, 2020). Understanding the chemical and physical properties of the backbone is therefore fundamental to both genetic engineering and the treatment of various malignancies and hereditary diseases.

Other names

Phosphodiester backboneSugar-phosphate backboneDNA backboneRNA backbone

Drugs targeting the phosphate backbone typically work through covalent alkylation, electrostatic binding, or by incorporating synthetic backbone modifications (e.g., phosphorothioates) to enhance stability and prevent enzymatic degradation by nucleases (Nature Reviews Drug Discovery, 2017).